Projected Income Statement: Akzo Nobel N.V.

Forecast Balance Sheet: Akzo Nobel N.V.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 2,398 4,089 3,785 3,901 2,942 2,916 2,675 2,221
Change - 70.52% -7.43% 3.06% -24.58% -0.88% -8.26% -16.97%
Announcement Date 2/9/22 2/8/23 2/7/24 1/28/25 2/3/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Akzo Nobel N.V.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 288 292 286 306 309 337.8 330.4 331.9
Change - 1.39% -2.05% 6.99% 0.98% 9.3% -2.16% 0.43%
Free Cash Flow (FCF) 1 317 -29 840 367 606 591.9 649.5 668.6
Change - -109.15% 2,996.55% -56.31% 65.12% -2.33% 9.73% 2.94%
Announcement Date 2/9/22 2/8/23 2/7/24 1/28/25 2/3/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Akzo Nobel N.V.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 14.98% 10.67% 13.4% 13.8% 14.22% 14.19% 14.86% 15.43%
EBIT Margin (%) 11.39% 7.27% 10.07% 10.39% 10.64% 10.51% 11.32% 11.89%
EBT Margin (%) 11.53% 5.55% 7.35% 7.82% 9.82% 8.36% 9.59% 10.2%
Net margin (%) 8.65% 3.25% 4.14% 5.06% 6.25% 5.49% 6.55% 7.06%
FCF margin (%) 3.31% -0.27% 7.87% 3.43% 5.97% 5.9% 6.32% 6.39%
FCF / Net Income (%) 38.24% -8.24% 190.05% 67.71% 95.43% 107.43% 96.52% 90.52%

Profitability

        
ROA 5.57% 2.99% 3.57% 4.6% 4.5% 3.96% 4.81% 5.23%
ROE 13.48% 8.77% 12.09% 14.91% 13.45% 12.5% 14.78% 15.01%

Financial Health

        
Leverage (Debt/EBITDA) 1.67x 3.53x 2.65x 2.64x 2.04x 2.05x 1.75x 1.37x
Debt / Free cash flow 7.56x -141x 4.51x 10.63x 4.85x 4.93x 4.12x 3.32x

Capital Intensity

        
CAPEX / Current Assets (%) 3% 2.69% 2.68% 2.86% 3.04% 3.37% 3.22% 3.17%
CAPEX / EBITDA (%) 20.06% 25.24% 20.01% 20.7% 21.4% 23.72% 21.64% 20.55%
CAPEX / FCF (%) 90.85% -1,006.9% 34.05% 83.38% 50.99% 57.06% 50.88% 49.64%

Items per share

        
Cash flow per share 1 3.27 1.505 6.6 6.249 5.351 4.769 5.902 6.414
Change - -53.97% 338.43% -5.32% -14.37% -10.88% 23.76% 8.67%
Dividend per Share 1 1.98 1.98 1.98 1.98 1.98 2.033 2.086 2.169
Change - 0% 0% 0% 0% 2.66% 2.64% 3.94%
Book Value Per Share 1 29.32 24.8 25.33 26.81 27.23 28.2 29.71 31.83
Change - -15.42% 2.14% 5.83% 1.56% 3.55% 5.36% 7.13%
EPS 1 4.46 2.01 2.59 3.17 3.71 3.207 3.988 4.36
Change - -54.93% 28.86% 22.39% 17.03% -13.55% 24.34% 9.33%
Nbr of stocks (in thousands) 182,386 177,400 170,595 170,779 171,042 171,250 171,250 171,250
Announcement Date 2/9/22 2/8/23 2/7/24 1/28/25 2/3/26 - - -
1EUR
Estimates
2026 *2027 *
P/E Ratio 18x 14.5x
PBR 2.05x 1.94x
EV / Sales 1.28x 1.22x
Yield 3.52% 3.61%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
57.78EUR
Average target price
61.71EUR
Spread / Average Target
+6.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AKZA Stock
  4. Financials Akzo Nobel N.V.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!